Skip to content

Advertisement

  • Research article
  • Open Access

Molybdate transporter ModABC is important for Pseudomonas aeruginosa chronic lung infection

  • 1, 2,
  • 1, 2,
  • 1, 2,
  • 1, 3, 4,
  • 1, 3, 4 and
  • 1, 2Email author
BMC Research Notes20169:23

https://doi.org/10.1186/s13104-016-1840-x

Received: 23 October 2015

Accepted: 6 January 2016

Published: 12 January 2016

Abstract

Background

Mechanisms underlying the success of Pseudomonas aeruginosa in chronic lung infection among cystic fibrosis (CF) patients are poorly defined. The modA gene was previously linked to in vivo competitiveness of P. aeruginosa by a genetic screening in the rat lung. This gene encodes a subunit of transporter ModABC, which is responsible for extracellular uptake of molybdate. This compound is essential for molybdoenzymes, including nitrate reductases. Since anaerobic growth conditions are known to occur during CF chronic lung infection, inactivation of a molybdate transporter could inhibit proliferation through the inactivation of denitrification enzymes. Hence, we performed phenotypic characterization of a modA mutant strain obtained by signature-tagged mutagenesis (STM_modA) and assessed its virulence in vivo with two host models.

Results

The STM_modA mutant was in fact defective for anaerobic growth and unable to use nitrates in the growth medium for anaerobic respiration. Bacterial growth and nitrate usage were restored when the medium was supplemented with molybdate. Most significantly, the mutant strain showed reduced virulence compared to wild-type strain PAO1 according to a competitive index in the rat model of chronic lung infection and a predation assay with Dictyostelium discoideum amoebae. As the latter took place in aerobic conditions, the in vivo impact of the mutation in modA appears to extend beyond its effect on anaerobic growth.

Conclusions

These results support the modABC-encoded transporter as important for the pathogenesis of P. aeruginosa, and suggest that enzymatic machinery implicated in anaerobic growth during chronic lung infection in CF merits further investigation as a potential target for therapeutic intervention.

Keywords

  • ModA
  • Molybdate
  • Pseudomonas aeruginosa
  • Cystic fibrosis
  • Anaerobic conditions
  • Biofilm
  • Chronic lung infection
  • Animal model

Background

Pseudomonas aeruginosa is an environmental bacterium and the most common cause of chronic lung infection among cystic fibrosis (CF) patients [1]. Its success in causing opportunistic infection and its persistence capacities are presumably attributable to a large 6.3–6.9 Mbp genome regulated by more than 550 transcriptional regulators, which allow adaptation to diverse environments and growth conditions [2, 3]. P. aeruginosa also produces a wide repertoire of molecules and sensors for nutrient uptake, adhesion, mobility, biofilm formation and antibiotic resistance that are all key components of in vivo proliferation [4].

It was shown that the CF mucus is oxygen-depleted [5] and may carry strict anaerobes [6]. Hence, during chronic lung infection in CF, P. aeruginosa is exposed to microaerophilic [7] or anaerobic conditions [8], which are well suited for biofilm formation [9]. Denitrification, the main source of energy production under anaerobic conditions, is based upon the reduction of oxidized forms of nitrogen (preferentially nitrates, NO3) by metalloenzymes such as nitrate reductase [10, 11]. Molybdate (MoO4 2−) is the usable form of trace-element molybdenum (Mo) [12] and resembles sulfate, phosphate, tungstate and vanadate in molecular size, shape, charge and hydrogen-binding properties [13]. Mo is incorporated into the molybdenum cofactor (MoCo) and was found to be essential for the activity of molybdoenzymes. These enzymes catalyze various oxidation/reduction reactions and are implicated in the metabolism of nitrogen, carbon and sulfur. All nitrate reductases required for P. aeruginosa anaerobic growth require a MoCo cofactor [11], which can contain either Mo or tungsten (W) [14].

A previous PCR-based signature-tagged mutagenesis (PCR-STM) mutant screen allowed the identification of 148 genes presumably essential for in vivo survival of P. aeruginosa PAO1 in a rat model of chronic lung infection [15]. One of these genes was modA. In E. coli, molybdate and tungstate are internalized using an ATP-binding cassette transporter, ModABC [16], where ModA is the periplasmic binding protein with a high affinity for Mo/W, ModB is the integral membrane channel protein and ModC is the energizer protein [17]. In P. aeruginosa, modA was recently demonstrated to be essential for molybdate acquisition and anaerobic growth using a deletion mutant [18]. Here, with the goal of gaining further information on the role of ModABC in the virulence of P. aeruginosa, we present a characterization of the PAO1 transposon mutant STM_modA. We then assess the relevance of modA as a therapeutic target by testing virulence attenuation of STM_modA in two host models: the rat model of chronic lung infection, which best represents the context of CF lung infections, and the amoeba predation assay, which takes place in aerobic conditions. Results suggest that modA is important for the pathogenesis of P. aeruginosa in both host models.

Methods

Bacterial strains, plasmids, primers and culture conditions

Bacterial strains and plasmids used in this study are listed in Table 1. The STM_modA mutant was constructed and identified in the context of PCR-based STM using strain PAO1 [15, 19, 20], a laboratory strain previously shown to be appropriate and comparable to a CF isolate (LESB58) for the study of virulence using the rat model of chronic lung infection [21]. Briefly, a tagged-miniTn5Km2 suicide plasmid was transferred into strain PAO1 by conjugation, generating thousands of mutants, each containing a unique random mutation. Mutant strains were then negatively screened in pools of 72 in the rat model of chronic lung infection to identify defective mutants for in vivo maintenance via multiplex PCR. Mutation of modA in the STM_modA mutant strain was confirmed by cloning using a plasmid rescue based on the miniTn5Km2 antibiotic resistance marker followed by sequencing and alignment on the PAO1 genome available at the Pseudomonas genome database [22].
Table 1

Strains and plasmids

Strain or plasmid

Relevant characteristics

Source or reference

E. coli strain

NEB 5α

Chemically competent cells

New England Biolabs

P. aeruginosa strains

PAO1

PAO1293, CmS, wild-type, derivative of PAO2 which originates from PAO1

[48]

STM_modA

PAO1 STM_modA::miniTn5-Km2 mutant inactivating modA (PA1863), KmR

[15]

Complemented STM_modA

PAO1 STM_modA with pUCP19::modABC plasmid (PA1863, PA1862, PA1861)

This study

Plasmids

pUCP19

CbR, cloning vector and used for CI

[49]

pUCP19 ::modABC

CbR, KmR, modABC genes on pUCP19 vector

This study

For routine cultures, P. aeruginosa and E. coli were grown aerobically at 37 °C in tryptic soy broth (TSB) or Luria–Bertani (LB) broth (EMD Serono). When needed, culture medium was supplemented with 1.5 (w/v) % bacto agar, kanamycin (Km 150 μg ml−1 for STM_modA; Calbiochem), ampicillin (Ap 100 μg ml−1 for DH10B transformants; Sigma-Aldrich) or carbenicillin (Cb 200 μg ml−1 for P. aeruginosa transformants; Thermo-Fisher).

For growth experiments, P. aeruginosa was grown aerobically under vigorous shaking (250 rpm) in 100 ml LB using a 1:10 pre-culture to Erlenmeyer volume ratio. For anaerobic growth, nephelo flasks sealed with silicone stoppers containing 100 ml LB were flushed with argon for 45 min and needle-inoculated with 1 ml of pre-culture before incubation with weak agitation (120 rpm) to prevent precipitation. Media for aerobic and anaerobic growth were supplemented with potassium nitrate (KNO3; 15 mM; Merck) and, when needed, sodium molybdate (100 μM; Sigma-Aldrich). Growth was monitored by spectrophotometric measurements of optical density at 600 nm. Growth experiments were repeated three times.

Restriction enzymes, Q5 polymerase and Gibson assembly cloning kit were purchased from New England Biolabs. The QIAprep Spin Miniprep Kit (Qiagen) was used for plasmid isolation and the DNeasy Blood and Tissue kit (Qiagen) was used for genomic DNA isolation. PCR reactions were performed in an iCycler (Bio-Rad); primers used in this study are listed in Additional file 1.

Spectrophotometric determination of nitrate in culture medium after anaerobic growth

To determine if the STM_modA mutant was able to use nitrates during anaerobic growth, the concentration of residual nitrates in the medium was quantified after overnight growth based on the principle of chemical reduction of nitrate and its spectrophotometric detection using the Griess reaction [23]. Vanadium (III) chloride (Sigma-Aldrich) was used for the reduction of nitrates to nitrites. Sulfanilamide and N-(1-naphtyl)-ethylenediamine (Sigma-Aldrich) were used in the composition of the Griess reagent. Nitrite concentration was subtracted from the total nitrate and nitrite concentration to obtain the nitrate concentration alone.

Complementation of the STM_modA mutation

Cloning of the modABC operon into the pUCP19 vector was done using the Gibson Assembly Master Mix (New England Biolabs) following manufacturer’s instructions. Two overlapping PCR fragments (Additional file 1) containing the entire modABC operon plus a 448 nt upstream region (2.1 kb final insert size) and an overlapping section of the KpnI and PstI restriction sites were ligated with the digested vector. The recombinant plasmid was introduced by heat shock into E. coli NEB 5α chemically competent cells (Table 1). The plasmid transfer was first confirmed by EcoRI and PstI digestion followed by DNA sequencing. The plasmid was then recovered and electroporated into the P. aeruginosa STM_modA mutant. Plasmid insertion in the mutant strain was confirmed using digestions with the same restriction enzymes.

Biofilm formation assay

Multiple phenotypic tests were performed for this study (see reference [24] for more information on the protocols used), but only biofilm formation showed variation among strains. To measure the quantity of biofilm produced by wild-type strain PAO1, STM_modA, and the complemented STM_modA, a 96-plate rapid biofilm formation assay was performed as previously described [25]. Briefly, strains were grown overnight in LB supplemented when needed with Km or Cb. The M63 culture medium for biofilm formation [25] was supplemented when needed with 100 μM sodium molybdate and 15 mM KNO3. Biofilms were stained with crystal violet after a 6-hour static incubation time. Biofilm formation was quantified after stain dissolution in 2 × 200 μl 95 % v/v ethanol [26]. The experiment was done three times, with eight repetitions for each strain and condition. Statistical significance was assessed using an ANOVA in GraphPad Prism 6.0.

Ethics statement

The rat model in this study was used in a protocol approved by the “Comité de protection des animaux de l’Université Laval” (certificate 2011194-3, IACUC is a Canadian Council on Animal Care certificate holder).

Preparation of agarose bead-embedded bacteria and in vivo competitive index

The previously described rat model of chronic lung infection [27] using agarose bead-embedded bacteria was optimized as described elsewhere [20]. Sprague–Dawley rats of 450–500 g in weight were sedated (ketamine/xylazine IP injection, 10 mg/100 g) and a local anesthetic (lidocaine) was applied to the vocal cords. Animals were then intubated and inoculated with 120 μl of bead preparation containing PAO1 + pUCP19 (CbR) strain and the STM_modA mutant in equal parts (1.6 × 106 CFU ml−1 per strain) for competitive index (CI) determination. At day 7 post-infection, rats were euthanized by barbiturate overdose (Euthanyl IP injection, 120 mg/kg) and homogenized lungs were diluted and plated in triplicate on TSA to quantify the total number of viable P. aeruginosa cells (TSA supplemented with 200 μg Cb ml−1 for the wild-type selection or TSA supplemented with 150 μg Km ml−1 for the mutant selection). In vivo CI was calculated as the ratio of mutant to wild-type bacteria recovered in vivo and adjusted according to the input ratio. The final CI data was represented as the geometric mean for each group of six animals and statistical significance was assessed with a two-tailed Mann–Whitney test on GraphPad Prism 6.0 software.

Amoeba predation assay

A predation assay was used to determine the bacterial capacity to resist to amoeba grazing [28]. The D. discoideum amoeba (DH1-10) was grown in HL5 medium (14.3 g l−1 of bactopeptone, 7.15 g l−1 of yeast extract, 18 g l−1 of d-(+)-monohydrate maltose, 0.641 g l−1 of Na2HPO4•2H2O, and 0.490 g l−1 of KH2PO4) [29] supplemented with 15 µg ml−1 tetracycline. The confluence of amoebae was about 60 % the day of the experiment. A volume of 300 µL of P. aeruginosa liquid pre-culture (OD600 = 0.9) was spread in a uniform lawn on a Petri dish containing SM 1/10 agar (1 g l−1 of bactopeptone, 0.1 g l−1 of yeast extract, 0.22 g l−1 of KH2PO4, 0.1 g l−1 of K2HPO4, 0.1 g l−1 of MgSO4∙7H2O, 2 g l−1 of Bacto agar, and 1 g l−1 of glucose). Serial 1/10 dilutions of 50,000 amoeba cells/5 µL down to 0 cell/5 µl were deposited on the bacterial lawn. Petri dishes were incubated at 21 °C for 7 days and phagocytic plaques due to amoeba grazing were monitored. The experiment was repeated three times.

Results and discussion

Genetic characterization of the P.aeruginosa STM_modA mutant

Sequencing of the mutated modA gene showed that the miniTn5 insertion and its typical 9-pb flanking duplication [30] were inserted in the open reading frame (ORF) of modA at position 540 (Fig. 1), and introduced a stop codon assumed to prematurely interrupt translation of the protein. In the 6.3 Mbp genome of P. aeruginosa strain PAO1, modA (PA1863) is encoded in a putative operon with modB (PA1862) and modC (PA1861) (Fig. 1). Their products correspond to the 26.4 kDa (252 AA) molybdate-binding periplasmic protein precursor ModA, molybdenum membrane transport protein ModB (24.4 kDa) and ATPase ModC (39.8 kDa). These annotations are based on AA identity with ModABC from E.coli [31], where the modABC transcription unit codes for an ATP-binding cassette (ABC) transporter of molybdate, and were confirmed by Pederick and colleagues [18] using a modA deletion mutant. Since ABC transporters require a binding protein to present the substrate to the cargo membrane protein(s) [32], ModABC is expected to be non-functional in the STM_modA mutant.
Figure 1
Fig. 1

Genomic organization of the P. aeruginosa modABC operon in the STM_modA mutant strain. The miniTn5 transposon is inserted at position 540. The modA gene encodes a 252 amino acid molybdate-binding periplasmic protein precursor. Products of modB and modC are the molybdenum transport protein ModB and ModC, respectively. Arrows indicate the direction of transcription and numbers are relative to the transcription start site of modA

modA is required for anaerobic growth and nitrate utilization

Under aerobic conditions, growth of STM_modA was equivalent to that of wild-type PAO1. In contrast, under anaerobic conditions where NO3 was provided as the terminal electron acceptor, the STM_modA mutant was unable to perform productive growth (Fig. 2a). However, when the growth medium was supplemented with 100 μM of sodium molybdate, mutant growth was restored to wild-type levels. Molybdate supplementation had no effect on PAO1 growth. Wild-type modABC was provided in trans to the mutant strain for complementation analysis using the expression vector pUCP19. The complemented STM_modA strain showed PAO1-like in vitro growth levels under anaerobic conditions (Fig. 2b), which confirmed that the disruption of modA is responsible for the STM_modA mutant phenotype in anaerobic conditions and that the ModABC transporter is essential for anaerobic growth. To confirm that this anaerobic growth defect was due to the malfunction of one or all nitrate reductases, residual nitrates in the growth medium were quantified (Fig. 2c). In the presence of nitrate reductase activity, nitrate concentration is expected to decrease due to bacterial uptake and subsequent reduction. After overnight growth, residual nitrates in the growth medium of wild-type PAO1 were completely consumed. In contrast, for the STM_modA mutant, nitrate concentration at the end of the experiment was identical to the initial concentration, demonstrating that no denitrification had occurred. When supplemented with molybdate, STM_modA showed PAO1-like nitrate consumption. Thus, nitrate consumption is molybdate-dependent in the STM_modA mutant.
Figure 2
Fig. 2

STM_modA is unable to perform anaerobic growth and use nitrates without molybdate supplementation. a anaerobic growth curves in LB medium supplemented with 15 mM KNO3, plus 100 μM sodium molybdate when indicated. STM_modA is unable to grow in anaerobic conditions with nitrates as the terminal electron acceptor without molybdate supplementation. Results are from three independent experiments; error bars represent standard deviation b anaerobic overnight growth in LB medium supplemented with 15 mM KNO3, plus 100 μM sodium molybdate when indicated. Addition of molybdate restored growth in the STM_modA mutant. The complemented STM_modA strain showed growth without molybdate supplementation. Statistical significance was assessed using an ANOVA in GraphPad prism 6.0 (*** p = 0.0003; **** p < 0.0001). c Residual nitrate dosage in the medium after overnight growth using the Griess reaction. Nitrates levels are inversely proportional to nitrate uptake and utilization. Adding molybdate to the medium restored the STM_modA mutant’s nitrate consumption. Results for b and c are for three technical replicates in one of three consistent experiments

It was previously demonstrated that mod mutations in E. coli caused pleiotropic effects on molybdo enzyme activity, including nitrate reductase activity [33]. These effects were reversible in the presence of high concentrations of molybdate, which can be internalized by the sulfate transport system under appropriate conditions [16, 34]. However, sulfur compounds have been shown to inhibit the sulfate transport system, thus in protein-rich medium (such as LB), molybdate is likely internalized by another, less specific transporter, presumably the selenite transport system [34]. A novel permease (PerO) internalizing molybdate at micromolar concentrations was identified in Rhodobacter capsulatus [35]. PerO also imports sulfate, tungstate and vanadate, suggesting a general oxyanion transporter function. PerO has 30 % AA sequence identity with P. aeruginosa PAO1 PA3839, which may be responsible for the nonspecific uptake of molybdate when added at micromolar concentrations, as was done here for the modA mutant.

modA and biofilm formation

The STM_modA mutant strain was tested in vitro for biofilm formation, H2O2 sensitivity, heat shock, proteolytic, lipolytic and hemolytic activities, swarming, twitching and swimming motilities, as well as pyocyanin and pyoverdine production. Among all tested phenotypic traits, only biofilm formation presented a statistically significant difference between STM_modA and wild-type PAO1 (Fig. 3a). To confirm whether the weak biofilm formation observed in STM_modA was caused by a defect in anaerobic growth in the presence of trace amounts of molybdate, the M63 medium was supplemented with molybdate alone, and with molybdate + KNO3. Results showed that the defect was independent from molybdate supplementation, which implies that reduced biofilm formation in STM_modA is not related to its growth defect in anaerobic conditions. When complemented using the recombinant plasmid encoding wild-type ModABC, biofilm formation was only partially restored (Fig. 3b). These results differ from those of Pederick and colleagues [18], according to which biofilm production was unaltered in the modA deletion mutant in 5 ml 24 h static cultures. This may be due, at least in part, to important differences between protocols, as biofilm formation is extremely sensitive to growth conditions e.g. [36]. Namely, the significant differences in volume and duration of the assay may have led to different oxygen gradients. If that was the case, it would imply that results from both studies on biofilm formation highlight the complex nature of this process in P. aeruginosa and should be interpreted with caution. However, since this study focusses on an insertional mutant, we cannot rule out the possibility of non-specific effects of the mutation, which may also explain this discrepancy. For instance, the gene adjacent to modA in the genome of strain PAO1, which was annotated as a putative transcriptional regulator, may be affected by the transposon insertion and result in pleiotropic effects. Further investigation would be required to confirm this gene’s function. It is noteworthy, however, that partial phenotype and/or virulence rescue was previously observed in other complemented P. aeruginosa mutants see reference [37], namely in mouse models of acute pneumonia and burn sepsis using the same plasmid [38]. Therefore, it is possible that a more general mechanism, which remains to be described, is responsible for these observations.
Figure 3
Fig. 3

Quantification of biofilm formation. a Relative biofilm production for wild-type PAO1 and the STM_modA mutant, in M63 medium supplemented with 100 μM sodium molybdate when indicated. Supplementation with KNO3 had no impact on these results. Statistically significant values were obtained using an ANOVA and Fisher’s LSD tests in GraphPad Prism 6.0 (****p < 0.0001). Biofilm formation was quantified by measuring the absorbance of crystal violet-stained attached cells, after a 6-hour incubation [25]. The data shown represent 8 replicates per strain for one of three consistent assays. STM_modA produces significantly less biofilm than PAO1 and this was not restored by the addition of molybdate and a source of electrons for anaerobic growth (denitrification). b Relative biofilm for PAO1, STM_modA and the complemented STM_modA in M63 medium. Biofilm formation was partly restored in the complemented strain (ANOVA and Fisher’s LSD, *p = 0.01, ****p < 0.0001)

modA is important for virulence during chronic lung infection

In the original screening experiment where the STM_modA mutant was targeted as defective for in vivo maintenance, pools of 72 STM mutant strains were tested simultaneously [15]. Therefore, further investigation was required to precisely describe the involvement of modA in the virulence of P. aeruginosa PAO1. An in vivo competitive index (CI) in the rat model of chronic lung infection was performed using both wild-type strain PAO1 and the STM_modA mutant. As depicted in Fig. 4, at 7 days post-infection, we recorded an in vivo CI value of 0.004, which represents a 250-fold decrease in mutant colony forming units (CFU) compared to the wild-type strain. Thus, STM_modA is unable to maintain a chronic lung infection in the rat model when in competition with wild-type PAO1. However, in aerobic combined culture conditions, PAO1 does not outcompete STM_modA, with an in vitro CI value of ~1.0 after 22 h. In addition, STM_modA was capable of normal growth in minimal M9 medium; hence it is not an auxotroph mutant. This contrast between in vitro and in vivo proliferation of the STM_modA mutant strain clearly stresses that mutation of modA has consequences that are relatively specific to the context of infection and probably influenced by the interaction with the host.
Figure 4
Fig. 4

In vivo competitive index (CI) of P. aeruginosa STM_modA in the rat lung. CI of STM_modA against wild-type PAO1 was determined 7 days post-infection. Each circle represents the CI for a single animal. A CI of less than one indicates a virulence defect. The geometric mean of the CI for all rats is shown as a solid line (****p < 0.0001, Mann–Whitney sum test)

modA is important for virulence in the amoeba model

In order to further investigate the idea that the role of modA in virulence may be affected by interaction with the host, we decided to use a markedly different host model. D. discoideum is an alternative model for the study of bacterial virulence where amoebae feed by bacterial uptake using phagocytosis [28, 39]. P. aeruginosa has universal virulence factors used to infect phylogenetically diverse hosts, which makes the amoeba model particularly well suited to study its virulence [28, 39]. Previously identified virulence factors using this model, related to quorum sensing and the type III secretion system, were also essential for infection in mammalian and insect models [40]. Many bacterial virulence factors are active against predation by D. discoideum, thus virulence is assumed to be inversely proportional to amoeba grazing [29, 39]. In addition, the predation assay is performed in aerobic conditions where no growth difference has been noticed between PAO1 and the STM_modA mutant.

As shown in Fig. 5, the STM_modA mutant was very susceptible to amoeba predation as shown by the presence of phagocytic plaques with only five D. dictostelium cells on a bacterial lawn of this mutant compared to PAO1, where a minimum of 5000 D. dictostelium cells was required to observe a phagocytic plaque. These results confirmed the virulence defect of the STM_modA mutant. As D. discoideum is an acute infection model while agar-embedded bacteria in the rat lung represent a chronic lung infection model, these two assays highlight the fact that modA may be important for the global virulence network of P. aeruginosa, even in aerobic conditions.
Figure 5
Fig. 5

D. discoideum predation assay. STM_modA exhibits a loss of resistance to amoeba predation when compared to the wild-type PAO1. Numbers represent D. discoideum cells deposited on the bacterial lawn. The number of phagocytic plaques is inversely proportional to predation resistance. PAO1 was grazed by a minimum of 5000 cells while STM_modA was sensitive to predation by only five cells. Results were consistent among three independently performed assays

Metabolic and molecular basis of STM_modA multi-host virulence

Results presented here independently confirmed that transport of the trace anion molybdate is essential for the activity of molybdoenzymes such as nitrate reductase in P. aeruginosa [18]. In anaerobic conditions, molybdate uptake was restored in STM_modA after the addition of molybdate to the culture medium, which suggests less specific internalization of the molecule by a system other than ModABC. The lack of anaerobic growth in STM_modA was hypothesized to be directly linked to the maintenance defect observed in the rat model of chronic lung infection (CI = 0.004) because this model mimics CF lung infections, which present evidence of oxygen-depletion [79, 41, 42]. This hypothesis, however, does not hold in the case of the amoeba predation assay, where a strong virulence defect was observed in at least partly aerobic conditions; oxygen availability may be limited in a fully grown bacterial lawn. For the biofilm formation assay, our results showed that STM_modA is unable to produce as much biofilm as PAO1 in vitro, and that this effect is molybdate-independent. As biofilm is a crucial component of P.aeruginosa chronic lung infections [43], reduced biofilm production in STM_modA may be related to the virulence defect observed in the rat model of chronic lung infection, in conjunction with anaerobic growth defectiveness. The virulence defect observed in the amoeba model, on the other hand, could be linked to this biofilm defect alone, as for other biofilm-defective mutants shown to have attenuated virulence in the D. dictostelium model [44]. Even without consideration for the biofilm results, which have been discussed at length earlier, the amoeba predation assay suggests that the impact of the mutation in modA may go beyond its effect on anaerobic growth, perhaps due to pleiotropic effects of this gene.

This study is not the first report of an impact on virulence for a gene implicated in molybdate homeostasis in P. aeruginosa. PA1006 encodes a protein of unknown function implicated in molybdate homeostasis that is critical for biofilm maturation and virulence in a lettuce model and in a burned mouse acute virulence model [45]. Other genes implicated in molybdenum utilization and transport (several moe, moa and mod genes) have been linked to a pathogenesis defect in Mycobacterium tuberculosis [46]. These genes were required for intracellular growth in macrophages or maintenance in the organs. Interestingly, modA has also been identified in a STM experiment with M. tuberculosis using a mouse model of acute lung infection with an intravenous administration route [47].

Conclusions

We have shown that the inactivation of the modA gene in a transposon mutant caused a significant defect in P. aeruginosa PAO1 for the establishment of chronic lung infection and for resistance to D. dictostelium predation. This study complements previous work [18] in providing evidence that molybdate uptake is important for anaerobic growth and multi-host virulence in P. aeruginosa. Since the capacity to thrive in anaerobic conditions is relevant to CF lung infections, the modABC-encoded transporter may represent a potential target for therapeutic intervention and deserves further investigation.

Declarations

Authors’ contributions

SP carried out all the experiments except for host model manipulation, performed statistical analyses and drafted the manuscript. JJ performed statistical analyses and drafted the manuscript. IKI performed the experiments with the rat model. MMO performed the amoeba predation assay. All authors read and approved final manuscript.

Acknowledgements

We are grateful to Anne Sebilo and Manon Couture for support and material used for anaerobic growth condition. We also thank Halim Maaroufi and Brian Boyle for collaboration on this project. The research in R.C.L.’s laboratory is funded by the Canadian Institute for Health Research as part of the CIHR Genomics Program operating grant (MOP-86644) and by Cystic Fibrosis Canada. RCL is a Fonds de la Recherche du Québec - Santé (FRQS) Research Scholar of Exceptional Merit. S.P. is a Master’s scholar from CIHR. J.J. is a Cystic Fibrosis Canada postdoctoral fellow. S.J.C. is a research scholar of the FRQS.

Competing interests

The authors declare that they have no competing interests.

Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.

Authors’ Affiliations

(1)
Institut de Biologie Intégrative et des Systèmes, Université Laval, Québec, Canada
(2)
Département de microbiologie-infectiologie-immunologie, Faculté de Médecine, Université Laval, Québec, Canada
(3)
Département de biochimie, de microbiologie et de bio-informatique, Faculté des Sciences et de Génie, Université Laval, Québec, Canada
(4)
Centre de recherche de l’Institut universitaire de cardiologie et de pneumologie de Québec (CRIUCPQ), Quebec, Canada

References

  1. Rosenfeld M, Gibson RL, McNamara S, Emerson J, Burns JL, Castile R, et al. Early pulmonary infection, inflammation, and clinical outcomes in infants with cystic fibrosis. Pediatr Pulmonol. 2001;32(5):356–66. doi:10.1002/ppul.1144.PubMedView ArticleGoogle Scholar
  2. Stover CK, Pham XQ, Erwin AL, Mizoguchi SD, Warrener P, Hickey MJ, et al. Complete genome sequence of Pseudomonas aeruginosa PAO1, an opportunistic pathogen. Nature. 2000;406(6799):959–64. doi:10.1038/35023079.PubMedView ArticleGoogle Scholar
  3. Silby MW, Winstanley C, Godfrey SA, Levy SB, Jackson RW. Pseudomonas genomes: diverse and adaptable. FEMS Microbiol Rev. 2011;35(4):652–80. doi:10.1111/j.1574-6976.2011.00269.x.PubMedView ArticleGoogle Scholar
  4. Balasubramanian D, Schneper L, Kumari H, Mathee K. A dynamic and intricate regulatory network determines Pseudomonas aeruginosa virulence. Nucleic Acids Res. 2013;41(1):1–20. doi:10.1093/nar/gks1039.PubMedPubMed CentralView ArticleGoogle Scholar
  5. Worlitzsch D, Tarran R, Ulrich M, Schwab U, Cekici A, Meyer KC, et al. Effects of reduced mucus oxygen concentration in airway Pseudomonas infections of cystic fibrosis patients. J Clin Invest. 2002;109(3):317–25. doi:10.1172/JCI13870.PubMedPubMed CentralView ArticleGoogle Scholar
  6. Tunney MM, Field TR, Moriarty TF, Patrick S, Doering G, Muhlebach MS, et al. Detection of anaerobic bacteria in high numbers in sputum from patients with cystic fibrosis. Am J Respir Crit Care Med. 2008;177(9):995–1001. doi:10.1164/rccm.200708-1151OC.PubMedView ArticleGoogle Scholar
  7. Alvarez-Ortega C, Harwood CS. Responses of Pseudomonas aeruginosa to low oxygen indicate that growth in the cystic fibrosis lung is by aerobic respiration. Mol Microbiol. 2007;65(1):153–65. doi:10.1111/j.1365-2958.2007.05772.x.PubMedPubMed CentralView ArticleGoogle Scholar
  8. Schobert M, Jahn D. Anaerobic physiology of Pseudomonas aeruginosa in the cystic fibrosis lung. Int J Med Microbiol. 2010;300(8):549–56. doi:10.1016/j.ijmm.2010.08.007.PubMedView ArticleGoogle Scholar
  9. Yoon SS, Hennigan RF, Hilliard GM, Ochsner UA, Parvatiyar K, Kamani MC, et al. Pseudomonas aeruginosa anaerobic respiration in biofilms: relationships to cystic fibrosis pathogenesis. Dev Cell. 2002;3(4):593–603.PubMedView ArticleGoogle Scholar
  10. Carlson CA, Ingraham JL. Comparison of denitrification by Pseudomonas stutzeri, Pseudomonas aeruginosa, and Paracoccus denitrificans. Appl Environ Microbiol. 1983;45(4):1247–53.PubMedPubMed CentralGoogle Scholar
  11. Arai H. Regulation and Function of Versatile Aerobic and Anaerobic Respiratory Metabolism in Pseudomonas aeruginosa. Front Microbiol. 2011;2:103. doi:10.3389/fmicb.2011.00103.PubMedPubMed CentralView ArticleGoogle Scholar
  12. Grunden AM, Shanmugam KT. Molybdate transport and regulation in bacteria. Arch Microbiol. 1997;168(5):345–54.PubMedView ArticleGoogle Scholar
  13. Frausto da Silva JJR, Williams RJP. The biological chemistry of the elements: the inorganic chemistry of life. Oxford: University press;1993.Google Scholar
  14. Schwartz G, Hagedoorn P-L, Fischer K. Molybdate and tungstate: uptake, homeostatis, cofactors, and enzymes. In: Nies DH, Silver S, editors. Molecular Microbiology of Heavy Metals. Berlin: Springer-Verlag; 2007.Google Scholar
  15. Potvin E, Lehoux DE, Kukavica-Ibrulj I, Richard KL, Sanschagrin F, Lau GW, et al. In vivo functional genomics of Pseudomonas aeruginosa for high-throughput screening of new virulence factors and antibacterial targets. Environ Microbiol. 2003;5(12):1294–308. doi:10.1046/j.1462-2920.2003.00542.x.PubMedView ArticleGoogle Scholar
  16. Rech S, Deppenmeier U, Gunsalus RP. Regulation of the molybdate transport operon, modABCD, of Escherichia coli in response to molybdate availability. J Bacteriol. 1995;177(4):1023–9.PubMedPubMed CentralGoogle Scholar
  17. Self WT, Grunden AM, Hasona A, Shanmugam KT. Molybdate transport. Res Microbiol. 2001;152(3–4):311–21.PubMedView ArticleGoogle Scholar
  18. Pederick VG, Eijkelkamp BA, Ween MP, Begg SL, Paton JC, McDevitt CA. Acquisition and role of molybdate in Pseudomonas aeruginosa. Appl Environ Microbiol. 2014;80(21):6843–52. doi:10.1128/aem.02465-14.PubMedPubMed CentralView ArticleGoogle Scholar
  19. Lehoux DE, Sanschagrin F, Levesque RC. Identification of in vivo essential genes from Pseudomonas aeruginosa by PCR-based signature-tagged mutagenesis. FEMS Microbiol Lett. 2002;210(1):73–80.PubMedView ArticleGoogle Scholar
  20. Sanschagrin F, Kukavica-Ibrulj I, Levesque RC. Essential genes in the infection model of Pseudomonas aeruginosa PCR-based signature-tagged mutagenesis. Methods Mol Biol. 2008;416:61–82. doi:10.1007/978-1-59745-321-9_5.PubMedView ArticleGoogle Scholar
  21. Kukavica-Ibrulj I, Bragonzi A, Paroni M, Winstanley C, Sanschagrin F, O’Toole GA, et al. In Vivo Growth of Pseudomonas aeruginosa Strains PAO1 and PA14 and the hypervirulent strain LESB58 in a rat model of chronic lung infection. J Bacteriol. 2008;190(8):2804–13. doi:10.1128/jb.01572-07.PubMedPubMed CentralView ArticleGoogle Scholar
  22. Winsor GL, Van Rossum T, Lo R, Khaira B, Whiteside MD, Hancock RE, et al. Pseudomonas Genome Database: facilitating user-friendly, comprehensive comparisons of microbial genomes. Nucleic Acids Res. 2009;37:483–8. doi:10.1093/nar/gkn861.View ArticleGoogle Scholar
  23. Miranda KM, Espey MG, Wink DA. A rapid, simple spectrophotometric method for simultaneous detection of nitrate and nitrite. Nitric Oxide. 2001;5(1):62–71. doi:10.1006/niox.2000.0319.PubMedView ArticleGoogle Scholar
  24. Jeukens J, Boyle B, Kukavica-Ibrulj I, Ouellet MM, Aaron SD, Charette SJ, et al. Comparative genomics of isolates of a Pseudomonas aeruginosa epidemic strain associated with chronic lung infections of cystic fibrosis patients. PLoS One. 2014;9(2):e87611. doi:10.1371/journal.pone.0087611.PubMedPubMed CentralView ArticleGoogle Scholar
  25. O’Toole GA. Microtiter dish biofilm formation assay. J Vis Exp. 2011;47:2437. doi:10.3791/2437.PubMedGoogle Scholar
  26. O’Toole GA, Kolter R. Initiation of biofilm formation in Pseudomonas fluorescens WCS365 proceeds via multiple, convergent signalling pathways: a genetic analysis. Mol Microbiol. 1998;28(3):449–61.PubMedView ArticleGoogle Scholar
  27. Cash HA, Woods DE, McCullough B, Johanson WG Jr, Bass JA. A rat model of chronic respiratory infection with Pseudomonas aeruginosa. Am Rev Respir Dis. 1979;119(3):453–9.PubMedGoogle Scholar
  28. Filion G, Charette SJ. Assessing Pseudomonas aeruginosa virulence using a nonmammalian host: Dictyostelium discoideum. Method Mol Biol. 2014;1149:671–80.View ArticleGoogle Scholar
  29. Froquet R, Lelong E, Marchetti A, Cosson P. Dictyostelium discoideum: a model host to measure bacterial virulence. Nat Protoc. 2009;4(1):25–30. doi:10.1038/nprot.2008.212.PubMedView ArticleGoogle Scholar
  30. Vizvaryova M, Valkova D. Transposons - the useful genetic tools. Biologia, Bratislava. 2004;59(3):309–18.Google Scholar
  31. Winsor GL, Lam DK, Fleming L, Lo R, Whiteside MD, Yu NY, et al. Pseudomonas genome database: improved comparative analysis and population genomics capability for Pseudomonas genomes. Nucleic Acids Res. 2011;39:596–600. doi:10.1093/nar/gkq869.View ArticleGoogle Scholar
  32. Hollenstein K, Dawson RJ, Locher KP. Structure and mechanism of ABC transporter proteins. Curr Opin Struct Biol. 2007;17(4):412–8. doi:10.1016/j.sbi.2007.07.003.PubMedView ArticleGoogle Scholar
  33. Glaser JH, DeMoss JA. Phenotypic restoration by molybdate of nitrate reductase activity in chlD mutants of Escherichia coli. J Bacteriol. 1971;108(2):854–60.PubMedPubMed CentralGoogle Scholar
  34. Lee JH, Wendt JC, Shanmugam KT. Identification of a new gene, molR, essential for utilization of molybdate by Escherichia coli. J Bacteriol. 1990;172(4):2079–87.PubMedPubMed CentralGoogle Scholar
  35. Gisin J, Muller A, Pfander Y, Leimkuhler S, Narberhaus F, Masepohl B. A Rhodobacter capsulatus member of a universal permease family imports molybdate and other oxyanions. J Bacteriol. 2010;192(22):5943–52. doi:10.1128/JB.00742-10.PubMedPubMed CentralView ArticleGoogle Scholar
  36. O’May CY, Reid DW, Kirov SM. Anaerobic culture conditions favor biofilm-like phenotypes in Pseudomonas aeruginosa isolates from patients with cystic fibrosis. FEMS Immunol Med Microbiol. 2006;48(3):373–80.PubMedView ArticleGoogle Scholar
  37. Kukavica-Ibrulj I, Sanschagrin F, Peterson A, Whiteley M, Boyle B, MacKay J, et al. Functional genomics of PycR, a LysR family transcriptional regulator essential for maintenance of Pseudomonas aeruginosa in the rat lung. Microbiology. 2008;154(7):2106–18. doi:10.1099/mic.0.2007/011239-0.PubMedView ArticleGoogle Scholar
  38. Lau GW, Britigan BE, Hassett DJ. Pseudomonas aeruginosa oxyr is required for full virulence in rodent and insect models of infection and for resistance to human neutrophils. Infect Immun. 2005;73(4):2550–3. doi:10.1128/iai.73.4.2550-2553.2005.PubMedPubMed CentralView ArticleGoogle Scholar
  39. Dallaire-Dufresne S, Paquet VE, Charette SJ. Dictyostelium discoideum: a model for the study of bacterial virulence. Can J Microbiol. 2011;57(9):699–707. doi:10.1139/w11-072.PubMedView ArticleGoogle Scholar
  40. Alibaud L, Kohler T, Coudray A, Prigent-Combaret C, Bergeret E, Perrin J, et al. Pseudomonas aeruginosa virulence genes identified in a Dictyostelium host model. Cell Microbiol. 2008;10(3):729–40. doi:10.1111/j.1462-5822.2007.01080.x.PubMedView ArticleGoogle Scholar
  41. Hassett DJ, Sutton MD, Schurr MJ, Herr AB, Caldwell CC, Matu JO. Pseudomonas aeruginosa hypoxic or anaerobic biofilm infections within cystic fibrosis airways. Trends Microbiol. 2009;17(3):130–8. doi:10.1016/j.tim.2008.12.003.PubMedView ArticleGoogle Scholar
  42. Palmer KL, Brown SA, Whiteley M. Membrane-bound nitrate reductase is required for anaerobic growth in cystic fibrosis sputum. J Bacteriol. 2007;189(12):4449–55. doi:10.1128/JB.00162-07.PubMedPubMed CentralView ArticleGoogle Scholar
  43. Hoiby N, Ciofu O, Bjarnsholt T. Pseudomonas aeruginosa biofilms in cystic fibrosis. Future Microbiol. 2010;5(11):1663–74. doi:10.2217/fmb.10.125.PubMedView ArticleGoogle Scholar
  44. Iwashkiw JA, Seper A, Weber BS, Scott NE, Vinogradov E, Stratilo C, et al. Identification of a general O-linked protein glycosylation system in Acinetobacter baumannii and its role in virulence and biofilm formation. PLoS Pathog. 2012;8(6):e1002758. doi:10.1371/journal.ppat.1002758.PubMedPubMed CentralView ArticleGoogle Scholar
  45. Filiatrault MJ, Tombline G, Wagner VE, Van Alst N, Rumbaugh K, Sokol P, et al. Pseudomonas aeruginosa PA1006, which plays a role in molybdenum homeostasis, is required for nitrate utilization, biofilm formation, and virulence. PLoS ONE. 2013;8(2):e55594. doi:10.1371/journal.pone.0055594.PubMedPubMed CentralView ArticleGoogle Scholar
  46. Williams M, Mizrahi V, Kana BD. Molybdenum cofactor: a key component of Mycobacterium tuberculosis pathogenesis? Crit Rev Microbiol. 2013;40:18–29. doi:10.3109/1040841X.2012.749211.PubMedView ArticleGoogle Scholar
  47. Camacho LR, Ensergueix D, Perez E, Gicquel B, Guilhot C. Identification of a virulence gene cluster of Mycobacterium tuberculosis by signature-tagged transposon mutagenesis. Mol Microbiol. 1999;34(2):257–67. doi:10.1046/j.1365-2958.1999.01593.x.PubMedView ArticleGoogle Scholar
  48. Holloway BW. Genetic recombination in Pseudomonas aeruginosa. J Gen Microbiol. 1955;13(3):572–81.PubMedGoogle Scholar
  49. Schweizer HP. Escherichia-Pseudomonas shuttle vector derived from pUC18/19. Gene. 1991;97(03838):109–12.PubMedView ArticleGoogle Scholar

Copyright

© Périnet et al. 2016

Advertisement